Rhee K, Thompson E A
Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston 77550, USA.
Mol Endocrinol. 1996 Dec;10(12):1536-48. doi: 10.1210/mend.10.12.8961264.
Glucocorticoids inhibit transcription of the murine cytoplasmic thymidine kinase gene (Tk-1). Glucocorticoid regulation of Tk-1 transcription can be demonstrated in cells that are arrested in late G1. This observation indicates that inhibition of Tk-1 expression is not dependent upon redistribution within the cell cycle but is due to glucocorticoid regulation of this gene. Transfection studies have been carried out using chimeric genes in which restriction fragments of the Tk-1 promoter were fused to chloramphenicol acetyltransferase or neomycin phosphotransferase. These chimeric reporters were assayed for stable expression and glucocorticoid regulation in P1798 lymphoma cells. A 140-bp fragment, extending from -143 to -3 bp with respect to the thymidine kinase translational start site, was capable of both basal and glucocorticoid-regulated transcription of reporter genes. The extent of inhibition by glucocorticoids was similar to that observed for the endogenous gene, and no increase in basal expression or the extent of inhibition was observed with constructs containing additional 5'-flanking DNA. The 140-bp Tk-1 core promoter fragment binds to transcription factors in extracts from P1798 cells. Control cell extracts contain factors that bind to and protect (from deoxyribonuclease I) a distal promoter element from -106 to -87 bp, relative to the translational start site. A second, proximal element was protected at -43 to -36 bp. The proximal element of the Tk-1 promoter resembles an RNA polymerase II initiator element. No other elements were protected. Glucocorticoids inhibit the amount or activity of the transcription factor that binds to this initiator-like element within the Tk-1 promoter. This element, when fused to upstream activation sequences from the herpes simplex virus thymidine kinase promoter, conveys glucocorticoid sensitivity in cis.
糖皮质激素抑制小鼠细胞质胸苷激酶基因(Tk - 1)的转录。Tk - 1转录的糖皮质激素调节可在停滞于G1晚期的细胞中得到证实。这一观察结果表明,Tk - 1表达的抑制并不依赖于细胞周期内的重新分布,而是由于该基因的糖皮质激素调节。已使用嵌合基因进行转染研究,其中Tk - 1启动子的限制片段与氯霉素乙酰转移酶或新霉素磷酸转移酶融合。在P1798淋巴瘤细胞中对这些嵌合报告基因进行了稳定表达和糖皮质激素调节的检测。相对于胸苷激酶翻译起始位点,从 - 143至 - 3 bp延伸的140 bp片段能够进行报告基因的基础转录和糖皮质激素调节的转录。糖皮质激素的抑制程度与内源性基因观察到的相似,并且含有额外5'侧翼DNA的构建体未观察到基础表达增加或抑制程度增加。140 bp的Tk - 1核心启动子片段与P1798细胞提取物中的转录因子结合。对照细胞提取物含有与相对于翻译起始位点从 - 106至 - 87 bp的远端启动子元件结合并保护(免受脱氧核糖核酸酶I作用)的因子。在 - 43至 - 36 bp处保护了第二个近端元件。Tk - 1启动子的近端元件类似于RNA聚合酶II起始元件。没有其他元件受到保护。糖皮质激素抑制与Tk - 1启动子内这种类似起始子元件结合的转录因子的量或活性。当该元件与单纯疱疹病毒胸苷激酶启动子的上游激活序列融合时,可顺式传递糖皮质激素敏感性。